Response to Letter Regarding Article, "Heart Failure, Saxagliptin and Diabetes Mellitus: Observations From the SAVOR-TIMI 53 Randomized Trial"

Affiliations

• ¹ TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA.
• ² Diabetes Unit, Division of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel.
• ³ Department of Pathology, Brigham and Women's Hospital, Boston, MA.
• ⁴ Cardiovascular Division, Women's College Hospital and Toronto General Hospital, University of Toronto, Toronto, Canada.
• ⁵ AstraZeneca Research and Development, Wilmington, DE.
• ⁶ Bristol-Myers Squibb, Princeton, NJ.
• ⁷ Cardiovascular Research Institute, Lady Davis Carmel Medical Center and Ruth and Bruce Rappaport School of Medicine Technion-IIT, Haifa, Israel.
• ⁸ Cardiovascular Medicine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX.
• ⁹ Division of Endocrinology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX.
• ¹⁰ Département Hospitalo-Universitaire FIRE, INSERM U-1148, Université Paris-Diderot, Hôpital Bichat, AP-HP, Paris, France, NHLI Imperial College, ICMS, Royal Brompton Hospital, London, UK.